Inhibition of Influenza Entry by Organosilicon Compounds

Area of Science:

• Virology
• Medicinal Chemistry
• Drug Discovery

Background:

• Influenza virus hemagglutinin (HA) is crucial for viral entry and a target for antiviral drugs.
• Tert-butylhydroquinone (TBHQ) was an early small molecule inhibitor of influenza entry, effective against Group 2 HA.
• TBHQ's instability due to oxidation limits its therapeutic potential.

Purpose of the Study:

• To enhance the stability and potency of TBHQ as an influenza entry inhibitor.
• To investigate the impact of replacing the tert-butyl group with tri-methyl silane (TMS) on TBHQ's antiviral properties.

Main Methods:

• Chemical modification of TBHQ by substituting the tert-butyl group with TMS.
• Assessment of compound stability in solution using analytical techniques.
• Evaluation of antiviral activity against influenza viruses using in vitro assays and NMR spectroscopy.

Main Results:

• Silicon-based TBHQ derivatives demonstrated improved stability compared to the parent compound.
• NMR analysis indicated stronger hydrophobic interactions of TMS-containing compounds within the HA binding pocket.
• TMS-modified compounds exhibited significantly increased in vitro activity against Group 2 HA-bearing influenza viruses.

Conclusions:

• Chemical modification, specifically the introduction of TMS, enhances the stability and potency of TBHQ derivatives.
• This strategy represents a novel approach for optimizing antiviral compounds targeting influenza HA.
• The developed silicon-based compounds show potential as effective influenza entry inhibitors.